Signaling from RAS to RAF: The Molecules and Their Mechanisms

被引:6
|
作者
Jeon, Hyesung [1 ,2 ]
Tkacik, Emre [1 ,3 ]
Eck, Michael J. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Harvard Med Sch, Syst Synthet & Quantitat Biol PhD Program, Boston, MA USA
基金
美国国家卫生研究院;
关键词
MAP kinase pathway; RAS/RAF; protein structure; signal transduction; cancer; RASopathies; PROTEIN PHOSPHATASE 2A; NOONAN-LIKE-SYNDROME; KSR-1 GENE ENCODES; B-RAF; C-RAF; CRYSTAL-STRUCTURE; KINASE-ACTIVITY; MEK INHIBITION; TARGETING RAF; WILD-TYPE;
D O I
10.1146/annurev-biochem-052521-040754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RAF family protein kinases are a key node in the RAS/RAF/MAP kinase pathway, the signaling cascade that controls cellular proliferation, differentiation, and survival in response to engagement of growth factor receptors on the cell surface. Over the past few years, structural and biochemical studies have provided new understanding of RAF autoregulation,RAF activation by RAS and the SHOC2 phosphatase complex, and RAF engagement with HSP90-CDC37 chaperone complexes. These studies have important implications for pharmacologic targeting of the pathway. They reveal RAF in distinct regulatory states and show that the functional RAF switch is an integrated complex of RAF with its substrate (MEK) and a 14-3-3 dimer. Here we review these advances, placing them in the context of decades of investigation of RAF regulation. We explore the insights they provide into aberrant activation of the pathway in cancer and RASopathies (developmental syndromes caused by germline mutations in components of the pathway).
引用
收藏
页码:289 / 316
页数:28
相关论文
共 50 条
  • [1] Ras and Raf signaling: From biology to therapeutics
    Marais, Richard M.
    CANCER RESEARCH, 2012, 72
  • [2] Deciphering Mechanisms of K-Ras Signaling through B-Raf Kinase
    Pathirage, Kasun
    Mattos, Carla
    PROTEIN SCIENCE, 2023, 32
  • [3] Ras-Raf signaling needs prohibitin
    Rajalingam, K
    Rudel, T
    CELL CYCLE, 2005, 4 (11) : 1503 - 1505
  • [4] Mechanisms of aneuploidy induction by RAS and RAF oncogenes
    Kamata, Tamihiro
    Pritchard, Catrin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (07): : 955 - 971
  • [5] Signaling through RAS-RAF-MEK-ERK: from basics to bedside
    Zebisch, Armin
    Czernilofsky, Armin P.
    Keri, Gyoergy
    Smigelskaite, Juja
    Sill, Heinz
    Troppmair, Jakob
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (05) : 601 - 623
  • [6] Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy
    Huang, Yunli
    Zhen, Yongqi
    Chen, Yanmei
    Sui, Shaoguang
    Zhang, Lan
    BIOCHEMICAL PHARMACOLOGY, 2023, 217
  • [7] Mechanisms of Raf-independent Ras transformation.
    Shields, JM
    Der, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3776S - 3776S
  • [8] Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
    Christoph K Weber
    Joseph R Slupsky
    Christian Herrmann
    Manuela Schuler
    Ulf R Rapp
    Christoph Block
    Oncogene, 2000, 19 : 169 - 176
  • [9] Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma
    Wang, Ao-Xue
    Qi, Xiao-Yi
    IUBMB LIFE, 2013, 65 (09) : 748 - 758
  • [10] Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
    Weber, CK
    Slupsky, JR
    Herrmann, C
    Schuler, M
    Rapp, UR
    Block, C
    ONCOGENE, 2000, 19 (02) : 169 - 176